Invention Grant
- Patent Title: Anti-tumor agent containing immunomodulator, and antitumor effect potentiator
-
Application No.: US16068573Application Date: 2017-01-06
-
Publication No.: US11612653B2Publication Date: 2023-03-28
- Inventor: Norihiko Suzuki
- Applicant: TAIHO PHARMACEUTICAL CO., LTD.
- Applicant Address: JP Chiyoda-ku
- Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee: TAIHO PHARMACEUTICAL CO., LTD.
- Current Assignee Address: JP Chiyoda-ku
- Agency: Oblon, McClelland, Maier & Neustadt, L.L.P.
- Priority: JPJP2016-002463 20160108,JPJP2016-119117 20160615
- International Application: PCT/JP2017/000266 WO 20170106
- International Announcement: WO2017/119484 WO 20170713
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K31/506 ; A61K31/7072 ; A61K45/06 ; C07K16/28 ; A61P35/00 ; A61K31/44 ; A61K31/53 ; A61K39/00
Abstract:
Provided is a novel cancer treatment method with less side effects, showing remarkably excellent antitumor effect.
An antitumor agent is used for administering a DNA function inhibitor and an immunomodulator in combination.
An antitumor agent is used for administering a DNA function inhibitor and an immunomodulator in combination.
Public/Granted literature
- US20190046639A1 ANTI-TUMOR AGENT CONTAINING IMMUNOMODULATOR, AND ANTITUMOR EFFECT POTENTIATOR Public/Granted day:2019-02-14
Information query
